Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · IEX Real-Time Price · USD
2.640
-0.010 (-0.38%)
At close: Apr 19, 2024, 4:00 PM
2.650
+0.010 (0.38%)
After-hours: Apr 19, 2024, 6:20 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $369.76 million as of April 19, 2024. Its market cap has increased by 201.84% in one year.
Market Cap
369.76M
Enterprise Value
306.09M
1-Year Change
201.84%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $113.10M to $369.76M, an increase of 226.93%. That is a compound annual growth rate of 26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 371.70M | 2.71% |
| Apr 17, 2024 | 361.90M | -4.08% |
| Apr 16, 2024 | 377.30M | 0.75% |
| Apr 15, 2024 | 374.50M | -1.83% |
| Apr 12, 2024 | 381.50M | -0.73% |
| Apr 11, 2024 | 384.30M | -6.81% |
| Apr 10, 2024 | 412.40M | -6.06% |
| Apr 9, 2024 | 439.00M | -1.26% |
| Apr 8, 2024 | 444.60M | -3.64% |
| Apr 5, 2024 | 461.40M | 0.92% |
| Apr 4, 2024 | 457.20M | -4.41% |
| Apr 3, 2024 | 478.30M | 0.89% |
| Apr 2, 2024 | 474.10M | -0.88% |
| Apr 1, 2024 | 478.30M | 3.35% |
| Mar 28, 2024 | 462.80M | 9.98% |
| Mar 27, 2024 | 420.80M | 10.88% |
| Mar 26, 2024 | 379.50M | -0.68% |
| Mar 25, 2024 | 382.10M | -0.34% |
| Mar 22, 2024 | 383.40M | 0.68% |
| Mar 21, 2024 | 380.80M | -4.51% |
| Mar 20, 2024 | 398.80M | 1.97% |
| Mar 19, 2024 | 391.10M | -1.61% |
| Mar 18, 2024 | 397.50M | -0.65% |
| Mar 15, 2024 | 400.10M | -0.94% |
| Mar 14, 2024 | 403.90M | -1.58% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 390.78M |
| Tevogen Bio Holdings | 388.49M |
| OraSure Technologies | 385.22M |
| Surmodics | 378.68M |
| Organogenesis Holdings | 377.41M |
| Pacific Biosciences of California | 375.13M |
| Anika Therapeutics | 373.49M |
| Solid Biosciences | 370.77M |